Abstract
The risk and benefit of mechanical interventions in valvular heart disease have been primarily described among patients with normal ejection fraction. The advent of nonsurgical mechanical interventions for aortic stenosis (transcatheter aortic valve replacement) may alter the risk-benefit ratio for patients who would otherwise be at increased risk for valve surgery. This review describes the epidemiology and pathophysiology of aortic stenosis with heart failure and reduced ejection fraction and summarizes the current registry and clinical trial data applicable to this frequently encountered high-risk group. It concludes with discussion of ongoing trials, new approaches, emerging indications, and a potential clinical algorithm incorporating optimal mechanical intervention for patients with aortic stenosis and concomitant reduced ejection fraction.
Original language | English (US) |
---|---|
Pages (from-to) | 3026-3041 |
Number of pages | 16 |
Journal | Journal of the American College of Cardiology |
Volume | 70 |
Issue number | 24 |
DOIs | |
State | Published - Dec 19 2017 |
Externally published | Yes |
Keywords
- aortic stenosis
- congestive heart failure
- transcatheter aortic valve replacement
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine